Literature DB >> 9000857

Myocardial viability.

Y Birnbaum1, R A Kloner.   

Abstract

Left ventricular function is a major predictor of outcome in patients with coronary artery disease. Acute ischemia, postischemic dysfunction (stunning), myocardial hibernation, or a combination of these 3 are among the reversible forms of myocardial dysfunction. In myocardial stunning, dysfunction occurs despite normal myocardial perfusion, and function recovers spontaneously over time. In acute ischemia and hibernation, there is regional hypoperfusion. Function improves only after revascularization. Evidence of myocardial viability usually relies on the demonstration of uptake of various metabolic tracers, such as thallium (thallous chloride TI 201) or fludeoxyglucose F 18, by dysfunctional myocardium or by the demonstration of contractile reserve in a dysfunctional region. This can be shown as an augmentation of function during the infusion of various sympathomimetic agents. The response of ventricular segments to increasing doses of dobutamine may indicate the underlying mechanism of dysfunction. Stunned segments that have normal perfusion show dose-dependent augmentation of function. If perfusion is reduced as in hibernating myocardium, however, a biphasic response usually occurs: function improves at low doses of dobutamine, whereas higher doses may induce ischemia and, hence, dysfunction. But in patients with severely impaired perfusion, even low doses may cause ischemia. Myocardial regions with subendocardial infarction or diffuse scarring may also have augmented contractility during catecholamine infusion due to stimulation of the subepicardial layers. In these cases, augmentation of function after revascularization is not expected. Because the underlying mechanism, prognosis, and therapy may differ among these conditions, it is crucial to differentiate among dysfunctional myocardial segments that are nonviable and have no potential to regain function, hibernating or ischemic segments in which recovery of function occurs only after revascularization, and myocardial stunning in which function is expected to recover spontaneously. Because combinations of all of these disorders may occur, even in the same segments, caution should be used in interpreting the imaging results.

Entities:  

Mesh:

Year:  1996        PMID: 9000857      PMCID: PMC1303873     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  56 in total

Review 1.  Myocardial 'stunning' in man.

Authors:  R Bolli
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

2.  Segmental wall motion abnormalities in the absence of clinically documented myocardial infarction: clinical significance and evidence of hibernating myocardium.

Authors:  S J Lewis; S G Sawada; T Ryan; D S Segar; W F Armstrong; H Feigenbaum
Journal:  Am Heart J       Date:  1991-04       Impact factor: 4.749

3.  The hibernating myocardium.

Authors:  S H Rahimtoola
Journal:  Am Heart J       Date:  1989-01       Impact factor: 4.749

4.  Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. With and without previous myocardial infarction.

Authors:  K Chatterjee; H J Swan; W W Parmley; H Sustaita; H S Marcus; J Matloff
Journal:  Circulation       Date:  1973-02       Impact factor: 29.690

Review 5.  Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium.

Authors:  V Dilsizian; R O Bonow
Journal:  Circulation       Date:  1993-01       Impact factor: 29.690

Review 6.  Therapy for myocardial stunning.

Authors:  Y Birnbaum; R A Kloner
Journal:  Basic Res Cardiol       Date:  1995 Jul-Aug       Impact factor: 17.165

7.  Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting.

Authors:  N Tamaki; Y Yonekura; K Yamashita; H Saji; Y Magata; M Senda; Y Konishi; K Hirata; T Ban; J Konishi
Journal:  Am J Cardiol       Date:  1989-10-15       Impact factor: 2.778

Review 8.  Left ventricular function and prognosis after myocardial infarction: rationale for therapeutic strategies.

Authors:  R Scognamiglio; G Fasoli; S Nistri; M Marin; S Dalla Volta
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

Review 9.  Nuclear imaging techniques for the assessment of myocardial viability.

Authors:  D Jain; B L Zaret
Journal:  Cardiol Clin       Date:  1995-02       Impact factor: 2.213

Review 10.  Dobutamine stress echocardiography for the diagnosis and management of coronary artery disease.

Authors:  M Tanimoto; R G Pai; W Jintapakorn; P M Shah
Journal:  Clin Cardiol       Date:  1995-05       Impact factor: 2.882

View more
  2 in total

1.  The search for viable myocardium.

Authors:  R O Bonow
Journal:  West J Med       Date:  1996-12

Review 2.  Role of cardiovascular magnetic resonance in acute and chronic ischemic heart disease.

Authors:  A Baritussio; A Scatteia; C Bucciarelli-Ducci
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-18       Impact factor: 2.357

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.